Retrospective Survey of Hyperkalemia in Hemodialysis

NCT05020717 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-08-25

No results posted yet for this study

Summary

This study aim to describe hyperkalemia clinical burden and investigate the risk factors associated with the burden on HD facility level.

Conditions

  • Hemodialysis Complication

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY
  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Li Zuo · Peking University People's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-08-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05020717 on ClinicalTrials.gov